nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
American Journal of Transplantation: Volume 21, Number 4, April 2021
|
|
|
|
21 |
4 |
p. i |
artikel |
2 |
A noninferiority design for a delayed calcineurin inhibitor substitution trial in kidney transplantation
|
Nickerson, Peter W. |
|
|
21 |
4 |
p. 1503-1512 |
artikel |
3 |
B cells and extracellular vesicles: New key players in solid organ transplantation?
|
Colas, Luc |
|
|
21 |
4 |
p. 1361-1362 |
artikel |
4 |
Biliary obstruction following ureteral revision of a transplanted kidney
|
Thiessen, Carrie |
|
|
21 |
4 |
p. 1657-1659 |
artikel |
5 |
B lymphocytes contribute to indirect pathway T cell sensitization via acquisition of extracellular vesicles
|
Becker, Pablo D. |
|
|
21 |
4 |
p. 1415-1426 |
artikel |
6 |
Combining cell-based therapy and normothermic machine perfusion for kidney graft conditioning has gone one step further
|
Steichen, Clara |
|
|
21 |
4 |
p. 1359-1360 |
artikel |
7 |
COVID-19 outcomes in patients waitlisted for kidney transplantation and kidney transplant recipients
|
Craig-Schapiro, Rebecca |
|
|
21 |
4 |
p. 1576-1585 |
artikel |
8 |
COVID-19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination — United States, September and December 2020
|
Nguyen, Kimberly H. |
|
|
21 |
4 |
p. 1650-1656 |
artikel |
9 |
Defining the roles and responsibilities of the kidney transplant medical director: A necessary step for future training, mentoring, and professional development
|
C. Wiseman, Alexander |
|
|
21 |
4 |
p. 1556-1563 |
artikel |
10 |
Delayed graft function and acute rejection following HLA-incompatible living donor kidney transplantation
|
Motter, Jennifer D. |
|
|
21 |
4 |
p. 1612-1621 |
artikel |
11 |
De novo HLA-alloimmunization to a kidney allograft incidentally without anastomoses
|
Friedersdorff, Frank |
|
|
21 |
4 |
p. 1665-1666 |
artikel |
12 |
Do anti-IL-6R blockers have a beneficial effect in the treatment of antibody-mediated rejection resistant to standard therapy after kidney transplantation?
|
Massat, Maéva |
|
|
21 |
4 |
p. 1641-1649 |
artikel |
13 |
Erratum
|
|
|
|
21 |
4 |
p. 1675 |
artikel |
14 |
Erratum
|
|
|
|
21 |
4 |
p. 1676-1677 |
artikel |
15 |
Expanding living donor liver transplantation: Report of first US living donor liver transplant chain
|
Braun, Hillary J. |
|
|
21 |
4 |
p. 1633-1636 |
artikel |
16 |
Factors associated with kidney graft survival in pure antibody-mediated rejection at the time of indication biopsy: Importance of parenchymal injury but not disease activity
|
Einecke, Gunilla |
|
|
21 |
4 |
p. 1391-1401 |
artikel |
17 |
Fatal metabolic stroke in a child with propionic acidemia 11 years post liver transplant
|
Sivananthan, Siyamini |
|
|
21 |
4 |
p. 1637-1640 |
artikel |
18 |
Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients
|
Harden, Paul N. |
|
|
21 |
4 |
p. 1603-1611 |
artikel |
19 |
Fecal microbiota transplant boosts cancer immunotherapy in patients
|
Li, Xian C. |
|
|
21 |
4 |
p. 1355 |
artikel |
20 |
Harnessing T cell exhaustion to improve solid organ transplant outcomes
|
Levitsky, Josh |
|
|
21 |
4 |
p. 1660-1661 |
artikel |
21 |
Impact of ischemia time on islet isolation success and posttransplantation outcomes: A retrospective study of 452 pancreas isolations
|
Wassmer, Charles-Henri |
|
|
21 |
4 |
p. 1493-1502 |
artikel |
22 |
Islet or pancreas after kidney transplantation: Is the whole still greater than some of its parts?
|
Fridell, Jonathan A. |
|
|
21 |
4 |
p. 1363-1364 |
artikel |
23 |
Is the outcome of SARS-CoV-2 infection in solid organ transplant recipients really similar to that of the general population?
|
Mendoza, Maria A. |
|
|
21 |
4 |
p. 1670-1671 |
artikel |
24 |
Liver transplantation in a patient after COVID-19 – Rapid loss of antibodies and prolonged viral RNA shedding
|
Niess, Hanno |
|
|
21 |
4 |
p. 1629-1632 |
artikel |
25 |
Management of lung transplantation in the COVID-19 era—An international survey
|
Coiffard, Benjamin |
|
|
21 |
4 |
p. 1586-1596 |
artikel |
26 |
Microvascular obstructions in portal bile duct capillaries and hepatic sinusoids during normothermic machine perfusion of marginal human livers
|
Tingle, Samuel J. |
|
|
21 |
4 |
p. 1662-1664 |
artikel |
27 |
Normothermic kidney perfusion: An overview of protocols and strategies
|
Elliott, Tegwen R. |
|
|
21 |
4 |
p. 1382-1390 |
artikel |
28 |
Novel delivery of cellular therapy to reduce ischemia reperfusion injury in kidney transplantation
|
Thompson, Emily R. |
|
|
21 |
4 |
p. 1402-1414 |
artikel |
29 |
Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes
|
Markmann, James F. |
|
|
21 |
4 |
p. 1477-1492 |
artikel |
30 |
Positive HCMV DNAemia in stem cell recipients undergoing letermovir prophylaxis is expression of abortive infection
|
Cassaniti, Irene |
|
|
21 |
4 |
p. 1622-1628 |
artikel |
31 |
Prediction is hard, especially regarding the future a
|
Smith, R. Neal |
|
|
21 |
4 |
p. 1357-1358 |
artikel |
32 |
Protective effect of a novel clinical-grade small molecule necrosis inhibitor against oxidative stress and inflammation during islet transplantation
|
Kim, Gyuri |
|
|
21 |
4 |
p. 1440-1452 |
artikel |
33 |
Quantifying infection risks in incompatible living donor kidney transplant recipients
|
Avery, Robin K. |
|
|
21 |
4 |
p. 1564-1575 |
artikel |
34 |
Response to “Is the outcome of SARS-CoV-2 infection in solid organ transplant recipients really similar to that of the general population?”
|
Molnar, Miklos Z. |
|
|
21 |
4 |
p. 1672-1673 |
artikel |
35 |
Response to “Is the outcome of SARS-CoV-2 infection in solid organ transplant recipients really similar to that of the general population?”
|
Alangaden, George J. |
|
|
21 |
4 |
p. 1674 |
artikel |
36 |
SARS-CoV-2 viral dynamics in immunocompromised patients
|
Caillard, Sophie |
|
|
21 |
4 |
p. 1667-1669 |
artikel |
37 |
Simultaneous bilateral laparoscopic nephrectomy with kidney transplantation in patients with ESRD due to ADPKD: A single-center experience
|
Abrol, Nitin |
|
|
21 |
4 |
p. 1513-1524 |
artikel |
38 |
Simultaneous robotic kidney transplantation and bariatric surgery for morbidly obese patients with end-stage renal failure
|
Spaggiari, Mario |
|
|
21 |
4 |
p. 1525-1534 |
artikel |
39 |
Spanish experience with heart transplants from controlled donation after the circulatory determination of death using thoraco-abdominal normothermic regional perfusion and cold storage
|
Miñambres, Eduardo |
|
|
21 |
4 |
p. 1597-1602 |
artikel |
40 |
T cell repertoire analysis suggests a prominent bystander response in human cardiac allograft vasculopathy
|
Habal, Marlena V. |
|
|
21 |
4 |
p. 1465-1476 |
artikel |
41 |
TGR5/Cathepsin E signaling regulates macrophage innate immune activation in liver ischemia and reperfusion injury
|
Zhou, Haoming |
|
|
21 |
4 |
p. 1453-1464 |
artikel |
42 |
The demise of islet allotransplantation in the United States: A call for an urgent regulatory update
|
Witkowski, Piotr |
|
|
21 |
4 |
p. 1365-1375 |
artikel |
43 |
The Economy of Transplant: Saving Money and Saving Lives
|
Pullen, Lara C. |
|
|
21 |
4 |
p. 1353-1354 |
artikel |
44 |
The use of third-party packed red blood cells during ex situ normothermic machine perfusion of organs for transplantation: Underappreciated complexities?
|
Callaghan, Chris J. |
|
|
21 |
4 |
p. 1376-1381 |
artikel |
45 |
TLR-MyD88 signaling blockades inhibit refractory B-1b cell immune responses to transplant-related glycan antigens
|
Sakai, Hiroshi |
|
|
21 |
4 |
p. 1427-1439 |
artikel |
46 |
Urinary liver-type fatty acid-binding protein is independently associated with graft failure in outpatient kidney transplant recipients
|
Yepes-Calderón, Manuela |
|
|
21 |
4 |
p. 1535-1544 |
artikel |
47 |
Validity and utility of urinary CXCL10/Cr immune monitoring in pediatric kidney transplant recipients
|
Blydt-Hansen, Tom D. |
|
|
21 |
4 |
p. 1545-1555 |
artikel |